Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Clinical trial NCT00979134 · TERMINATED
Trial details
- NCT number
- NCT00979134
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-21
- Primary completion
- 2014-02-12
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.